Notably, high infiltration of CD163+ TAMs in microenvironment has been reported to be associated with poor prognosis in RCC [22], promoting cancer cell proliferation through direct cell–cell interactions [23]; this concept was already well known in the pre immunotherapy era of renal carcinoma [24]. Here, CD163 is linked to renal cell carcinoma.